GPA512

a prodrug of STAT3 inhibitor galiellalactone; structure in first source

Also Known As:

3-(N-acetylcysteine methyl ester)-2a,3-dihydrogaliellalactone

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Bjartell, Anders: 1 article (01/2016)
2.	Canesin, Giacomo: 1 article (01/2016)
3.	Escobar, Zilma: 1 article (01/2016)
4.	Evans-Axelsson, Susan: 1 article (01/2016)
5.	Hellsten, Rebecka: 1 article (01/2016)
6.	Johansson, Martin H: 1 article (01/2016)
7.	Sterner, Olov: 1 article (01/2016)

1.	Prostatic Neoplasms (Prostate Cancer) 01/01/2016 - "Preclinical Characterization of 3β-(N-Acetyl l-cysteine methyl ester)-2aβ,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate Cancer."

1.	Prodrugs